Review of a new fully liquid, hexavalent vaccine: Hexaxim

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.13, Iss.4, 2013-04, pp. : 575-593

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Correction: Review of a new fully liquid, hexavalent vaccine: Hexaxim

Expert Opinion on Biological Therapy, Vol. 13, Iss. 6, 2013-08 ,pp. : 949-949

Informa Healthcare

Access to resources Recommend Favorite

New tuberculosis vaccine development

By Nacy Carol A Sacksteder Katherine A

Expert Opinion on Biological Therapy, Vol. 2, Iss. 7, 2002-10 ,pp. : 741-749

Informa Healthcare

Access to resources Recommend Favorite

New adjuvants in evolving vaccine strategies

By Buonaguro Franco M Tornesello Maria Lina Buonaguro Luigi

Expert Opinion on Biological Therapy, Vol. 11, Iss. 7, 2011-07 ,pp. : 827-832

Informa Healthcare

Access to resources Recommend Favorite

Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement

By Ansaldi Filippo Durando Paolo Icardi Giancarlo

Expert Opinion on Biological Therapy, Vol. 11, Iss. 3, 2011-03 ,pp. : 415-427

Informa Healthcare

Access to resources Recommend Favorite

A review of vaccine clinical trials for non-small cell lung cancer

By Nemunaitis J Nemunaitis J

Expert Opinion on Biological Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. : 89-102

Informa Healthcare

Access to resources Recommend Favorite